Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CFC metered-dose inhaler ban would require FDA/EPA certification for removal -- bill.

This article was originally published in The Tan Sheet

Executive Summary

METERED-DOSE INHALERS WITH CFCs WOULD REQUIRE FDA/EPA SIGN-OFF for removal from the market with the provision being equally applicable to Rx and OTC products under a bill (S 1299) introduced by Sen. Tim Hutchinson (R-Ark.) Oct. 21. Hutchinson's bill would require FDA and the Environmental Protection Agency to "jointly certify to the Congress that alternatives to such inhalers are available that, for all populations of users of such inhalers, are comparable in terms of safety and effectiveness, therapeutic indications, dosage strength, costs and retail availability."

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS087691

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel